Rapid Micro Biosystems, Inc.
RPID · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 24.6% | 31.4% | -26.3% | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | -0.4% | -24.4% | -49.8% | -33.3% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -166% | -237.4% | -352.4% | -196.7% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -167.2% | -233% | -354.9% | -316.5% |
| EPS Diluted | -1.08 | -1.22 | -1.43 | -1.88 |
| % Growth | 11.5% | 14.7% | 23.9% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |